Cancer care in the UK does not match the best in Europe, which is costing the UK 10 000 lives per year, the national clinical director for cancer

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.619, 2011-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploring variations in lung cancer care across the UK - the ‘story so far’ for the National Lung Cancer Audit

By Beckett P   Woolhouse I   Stanley R   Peake MD  

Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. : 14-18

Royal College Of Physicians

Access to resources Recommend Favorite

Variation in lung cancer outcomes in the UK and Europe

By Woolhouse Ian  

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 110-111

Royal College Of Physicians

Access to resources Recommend Favorite

Screening embryos for cancer in the UK

By  

Reproductive BioMedicine Online, Vol. 11, Iss. 4, 2005-10 ,pp. : 485-485

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

UK NHS 10-year blueprint revealed

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 274, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Funding for cancer drugs in Australia and the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 610, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite